Effect of breast cancer as the first or second primary cancer on the prognosis of women with thyroid cancer: a SEER database analysis

被引:2
作者
Huang, Jianglong [1 ]
Huang, Yihui [1 ]
Zhou, Ling [1 ]
Chen, Sichao [1 ]
Chen, Danyang [1 ]
Wei, Wei [2 ]
Zhang, Chao [3 ]
Wang, Min [1 ]
Zhou, Wei [1 ]
Zeng, Wen [4 ]
Liu, Zeming [1 ]
Guo, Liang [1 ]
机构
[1] Wuhan Univ, Dept Plast Surg, Zhongnan Hosp, Donghu Rd 169, Wuhan, Peoples R China
[2] St John Hosp & Med Ctr, Dept Pediat, Detroit, MI USA
[3] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Cardiovasc Surg, Wuhan, Peoples R China
[4] Wuhan Univ, Zhongnan Hosp, Dept Ophthalmol, Wuhan, Peoples R China
关键词
Breast neoplasms; second primary neoplasms; Surveillance; Epidemiology; and End Results (SEER); survival; thyroid neoplasms; PRIMARY MALIGNANCY; SURVIVORS; RISK; ASSOCIATION;
D O I
10.21037/tcr-20-2243
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Although many studies have evaluated the association between breast cancer (BC) and thyroid cancer (TC), this association has not been completely studied. In this study, we focused on the effect of BC as the first or second primary cancer on survival among women with TC. We present the following article in accordance with the STROBE reporting checklist. Methods: Using the Surveillance, Epidemiology, and End Results (SEER) database, we performed a retrospective cohort analysis of 134,785 women with BC and TC between 1974 and 2016. The patients were divided into three subgroups, namely, TC only (TC group, n=128,888), BC after TC (TC2BC group, n=3,000), and BC before TC (BC2TC group, n=2,897). The curves for overall survival (OS) and cancer-specific survival (CSS) were evaluated, and Cox regression analyses were performed to examine the effect of BC as the first and second primary cancer on the CSS and OS of TC patients. Results: The CSS rates in the TC, TC2BC, and BC2TC groups were 96.96%, 98.70%, and 96.70%, respectively, and the OS rates were 91.17%, 77.13%, and 78.63%, respectively. Using the TC group as a reference, the hazard ratios (HRs) for the CSS of the TC2BC and BC2TC groups were 0.333 [95% confidence interval (CI): 0.243-0.456, P<0.001] and 1.299 (95% CI: 1.062-1.589, P=0.011), respectively. The corresponding HRs for the OS were 1.544 (95% CI: 1.428-1.668, P<0.001) and 3.429 (95% CI: 3.158-3.724, P<0.001), respectively. Conclusions: Among the female patients with TC, BC, as the second primary cancer, has a significant protective effect on the CSS of TC patients; however, when BC is the first primary cancer, it is a risk factor. Besides, BC is a risk factor for the OS of TC patients, especially for patients who develop TC after BC.
引用
收藏
页码:6955 / 6962
页数:8
相关论文
共 21 条
  • [1] A Possible Association Between Thyroid Cancer and Breast Cancer
    An, Jee Hyun
    Hwangbo, Yul
    Ahn, Hwa Young
    Keam, Bhumsuk
    Lee, Kyu Eun
    Han, Wonshik
    Park, Do Joon
    Park, In Ae
    Noh, Dong-Young
    Youn, Yeo-Kyu
    Cho, Bo Youn
    Im, Seock-Ah
    Park, Young Joo
    [J]. THYROID, 2015, 25 (12) : 1330 - 1338
  • [2] Decreased breast cancer-specific mortality risk in patients with a history of thyroid cancer
    Cheng, Weiwei
    Shen, Xiaopei
    Xing, Mingzhao
    [J]. PLOS ONE, 2019, 14 (10):
  • [3] Nulliparity enhances the risk of second primary malignancy of the breast in a cohort of women treated for thyroid cancer
    Consorti, Fabrizio
    Di Tanna, Gianluca
    Milazzo, Francesca
    Antonaci, Alfredo
    [J]. WORLD JOURNAL OF SURGICAL ONCOLOGY, 2011, 9
  • [4] Thyroid Hormone in the Clinic and Breast Cancer
    Hercbergs, Aleck
    Mousa, Shaker A.
    Leinung, Matthew
    Lin, Hung-Yun
    Davis, Paul J.
    [J]. HORMONES & CANCER, 2018, 9 (03): : 139 - 143
  • [5] Inducing or Preventing Subsequent Malignancies for Breast Cancer Survivors? Double-edged Sword of Estrogen Receptor and Progesterone Receptor
    Hu, Zhe-Yu
    Xiao, Huawu
    Xiao, Mengjia
    Tang, Yu
    Sun, Jian
    Xie, Ze-Ming
    Ouyang, Quchang
    [J]. CLINICAL BREAST CANCER, 2018, 18 (05) : E1149 - E1163
  • [6] Association between breast cancer and thyroid cancer: A study based on 13 978 patients with breast cancer
    Huang, Nai-si
    Chen, Xing-xing
    Wei, Wen-jun
    Mo, Miao
    Chen, Jia-ying
    Ma, Ben
    Yang, Shu-wen
    Xu, Wei-bo
    Wu, Jiong
    Ji, Qing-hai
    Guo, Xiao-mao
    Liu, Guang-yu
    Shao, Zhi-min
    Wang, Yu
    [J]. CANCER MEDICINE, 2018, 7 (12): : 6393 - 6400
  • [7] Risk of Second Non-Breast Primary Cancer in Male and Female Breast Cancer Patients: A Population-Based Cohort Study
    Hung, Man-Hsin
    Liu, Chia-Jen
    Teng, Chung-Jen
    Hu, Yu-Wen
    Yeh, Chiu-Mei
    Chen, San-Chi
    Chien, Sheng-Hsuan
    Hung, Yi-Ping
    Shen, Cheng-Che
    Chen, Tzeng-Ji
    Tzeng, Cheng-Hwai
    Liu, Chun-Yu
    [J]. PLOS ONE, 2016, 11 (02):
  • [8] The association between breast cancer and thyroid cancer: a meta-analysis
    Joseph, Kyle R.
    Edirimanne, Senarath
    Eslick, Guy D.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2015, 152 (01) : 173 - 181
  • [9] Breast cancer in thyroid cancer survivors: An analysis of the Surveillance, Epidemiology, and End Results-9 database
    Kuo, Jennifer H.
    Chabot, John A.
    Lee, James A.
    [J]. SURGERY, 2016, 159 (01) : 23 - 29
  • [10] Breast cancer prognosis is better in patients who develop subsequent metachronous thyroid cancer
    Lei, Kefeng
    He, Xujun
    Yu, Leibo
    Ni, Chao
    Chen, Hailong
    Guan, Dandan
    Sun, Kewang
    Zou, Hai
    [J]. PLOS ONE, 2019, 14 (05):